Minimally Invasive Gastrointestinal Surgical Systems Market Report 2025

The minimally invasive gastrointestinal surgical systems market size has grown strongly in recent years. It will grow from $6.66 billion in 2024 to $7.22 billion in 2025 at a compound annual growth rate (CAGR) of 8.4%. The growth during the historic period can be attributed to the increasing adoption of endoscopic technologies in surgical procedures, a rising elderly population requiring gastrointestinal treatments, expanded availability of advanced surgical training programs, a growing preference for outpatient surgeries, and heightened demand for cosmetic and minimally scarring surgical options.

The minimally invasive gastrointestinal surgical systems market size is expected to see strong growth in the next few years. It will grow to $9.84 billion in 2029 at a compound annual growth rate (CAGR) of 8.1%. The growth in the forecast period can be attributed to the increasing integration of robotic systems in gastrointestinal surgeries, rising investments in healthcare infrastructure in emerging markets, growing demand for AI-assisted surgical tools, a stronger focus on personalized and precision surgical procedures, and the expanding adoption of telesurgery and remote-assisted operations. Key trends during this period include advancements in robotic-assisted minimally invasive surgical platforms, development of AI-powered decision support systems for surgeons, innovations in flexible endoscopic instruments for complex procedures, progress in real-time imaging and navigation technologies, and the emergence of single-port and scarless surgical techniques.

The increasing prevalence of gastrointestinal disorders is expected to drive growth in the minimally invasive gastrointestinal surgical systems market in the coming years. Gastrointestinal disorders affect the digestive system, including the stomach, intestines, and related organs causing symptoms such as pain, bloating, diarrhea, and constipation. Their rise is largely attributed to poor dietary habits, as higher consumption of processed and low-fiber foods disrupts digestion and negatively impacts gut health over time. Minimally invasive gastrointestinal surgical systems facilitate the treatment of these disorders by enabling precise and efficient procedures that reduce complications and support faster patient recovery. For example, according to the UK Health Security Agency, a UK-based government department, gastrointestinal infection rates in England increased by 27%, from 96.1 per 100,000 in 2022 to 122 in 2024. Consequently, the growing prevalence of gastrointestinal disorders is fueling the expansion of the minimally invasive gastrointestinal surgical systems market.

Key players in the minimally invasive gastrointestinal surgical systems market are developing innovative solutions, such as open consoles integrated with 3D display technology, to improve surgical precision and visualization, thereby enhancing patient outcomes. An open console with 3D display is an interactive system that combines an open-access command console with three-dimensional visualizations for improved user interaction and data interpretation. For instance, in May 2025, Medtronic Plc, an Ireland-based medical technology company, launched the Hugo robotic-assisted surgery (RAS) system in Korea for the first time. The system features a modular design, an open console with a 33-inch 3D display, and versatile applications across urological, gynecological, and general surgeries. This launch enhances surgical precision and team communication while positioning Seoul National University Hospital as a leading center for robotic surgery research, education, and expanded clinical applications in Korea.

In November 2024, Medtronic Plc acquired Fortimedix Surgical for an undisclosed amount. Through this acquisition, Medtronic aims to broaden its minimally invasive surgical portfolio by incorporating Fortimedix Surgical’s advanced surgical technologies. Fortimedix Surgical, based in the Netherlands, develops innovative medical devices for minimally invasive gastrointestinal (GI) surgeries, particularly those involving endoscopy and single-port access.

Major players in the minimally invasive gastrointestinal surgical systems market are Johnson & Johnson, Fujifilm Holdings Corporation, Stryker Corporation, Boston Scientific Corporation, Zimmer Biomet Holdings Inc., Intuitive Surgical Inc., HOYA Corporation, Smith & Nephew Plc, Teleflex Incorporated, Karl Storz SE & Co. KG, Cook Medical LLC, CONMED Corporation, Applied Medical Resources Corporation, Pentax Medical Corp., Ambu A/S, Richard Wolf GmbH, B. Braun Melsungen AG, W. L. Gore & Associates Inc., Microline Surgical Inc., and Xenocor Inc.

North America was the largest region in the minimally invasive gastrointestinal surgical systems market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in minimally invasive gastrointestinal surgical systems market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the minimally invasive gastrointestinal surgical systems market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The fast surge in U.S. tariffs and the trade tensions that followed in spring 2025 are heavily affecting the medical equipment sector, particularly for imported imaging machine components, surgical-grade stainless steel, and plastic disposables. Hospitals and clinics resist price hikes, pressuring manufacturers’ margins. Regulatory hurdles compound the problem, as tariff-related supplier changes often require re-certification of devices, delaying time-to-market. Companies are mitigating risks by dual-sourcing critical parts, expanding domestic production of commoditized items, and accelerating R&D in cost-efficient materials.

Minimally invasive gastrointestinal surgical systems are advanced technologies designed to perform procedures within the digestive tract through small incisions or natural orifices. These systems feature sophisticated tools and imaging capabilities that enable precise surgical movements and improved visualization during procedures.

The primary types of minimally invasive gastrointestinal surgical systems include endoscopic equipment, laparoscopic equipment, robotic surgical systems, access devices, and visualization systems. Endoscopic equipment consists of devices that allow visualization and intervention within the gastrointestinal tract with minimal incisions. These systems employ various technologies such as traditional laparoscopy, robotic-assisted laparoscopy, single-incision surgery, natural orifice transluminal endoscopic surgery (NOTES), and augmented reality-guided surgery. They are used for multiple procedures, including adrenalectomy, appendectomy, bariatric surgery, cholecystectomy, colon and rectal surgery, foregut surgery, hernia repair, and others. The systems serve a wide range of end users, including hospitals, ambulatory surgical centers (ASCs), clinics, research and academic institutions, and healthcare compliance organizations.

The minimally invasive gastrointestinal surgical systems market research report is one of a series of new reports that provides minimally invasive gastrointestinal surgical systems market statistics, including the minimally invasive gastrointestinal surgical systems industry global market size, regional shares, competitors with the minimally invasive gastrointestinal surgical systems market share, detailed minimally invasive gastrointestinal surgical systems market segments, market trends, and opportunities, and any further data you may need to thrive in the minimally invasive gastrointestinal surgical systems industry. This minimally invasive gastrointestinal surgical systems market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The minimally invasive gastrointestinal surgical systems market consists of revenues earned by entities by providing services such as preoperative assessment, imaging services, anesthesia services, intraoperative monitoring, and postoperative care. The market value includes the value of related goods sold by the service provider or included within the service offering. The minimally invasive gastrointestinal surgical systems market also includes sales of trocar systems, insufflators, surgical staplers, and hand instruments. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.